This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as interchangeable. Its value is real, but it remains a narrative review, not a new trial, so its conclusions should be read as framing and synthesis rather than definitive proof.
Air Canada employee swaps passenger’s luggage tags to traffic cannabis: RCMP – MSN
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CannabisTravel MedicinePatient AccessRegulatory ComplianceLegal Issues Why This MattersThis case highlights ongoing regulatory inconsistencies...
Aurora Cannabis (TSE:ACB) Sets New 1-Year Low – Time to Sell? – MarketBeat
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Industry StabilitySupply ChainMedical CannabisMarket AccessTreatment Continuity Why This MattersStock volatility in major cannabis companies...
Stocks in play: Aurora Cannabis Inc. – Yahoo Finance
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CannabisSupply ChainProduct AccessIndustryPatient Care Why This MattersStock market movements of cannabis companies often...
Survey: More than half of Washington clinicians cite mental-health risks from cannabis use
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthClinical EducationRisk AssessmentThcMedical Cannabis Why This MattersThis survey reflects a critical gap between...
Air Canada employee swaps passenger’s luggage tags to traffic cannabis – Global News
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CannabisTravel RegulationsLegal CompliancePatient SafetyCross-Border Transport Why This MattersThis case highlights the ongoing regulatory...
Terra Pharm Opens Cultivation Facility and Dispensaries in Pennsylvania
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessMedical CannabisPennsylvaniaSupply ChainPatient Care Why This MattersPennsylvania's medical cannabis program expansion affects patient access...
Mother of first legal cannabis patient says other users abuse system – The Times
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical CannabisPolicyPatient AdvocacyRegulatory ComplianceUk Healthcare Why This MattersWhen legitimate medical cannabis patients or their...
Michigan marijuana industry files second lawsuit over 24% tax – The Detroit News
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessPolicyPatient CostMedical CannabisHealthcare Economics Why This MattersTax policy directly affects patient access to cannabis...
Terra Pharm Medical Marijuana Organization Opens Cultivation Facility and Dispensaries in …
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AccessQuality ControlDispensariesSupply ChainMedical Cannabis Why This MattersNew cultivation and dispensary operations directly impact product...